Logo

HWKN

Hawkins, Inc.

HWKN

Hawkins, Inc. • NASDAQ
$130.02 ▼ -0.78% (-1.02)
Market Cap $2.71 B
52w High $186.15
52w Low $98.30
Dividend Yield 0.76%
P/E 32.75
Volume 67.75K
Outstanding Shares 20.87M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q2-2026 $280.434M ▼ $33.703M ▲ $22.598M ▼ 8.058% ▼ $1.09 ▼ $47.923M ▼
Q1-2026 $293.272M ▲ $31.029M ▲ $29.175M ▲ 9.948% ▲ $1.41 ▲ $54.566M ▲
Q4-2025 $245.318M ▲ $27.662M ▲ $16.327M ▲ 6.655% ▲ $0.79 ▲ $34.528M ▲
Q3-2025 $226.205M ▼ $27.361M ▲ $15.021M ▼ 6.64% ▼ $0.72 ▼ $21.063M ▼
Q2-2025 $247.029M $26.477M $24.118M 9.763% $1.16 $44.345M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q2-2026 $10.415M ▼ $984.164M ▼ $477.196M ▼ $506.968M ▲
Q1-2026 $14.502M ▲ $988.274M ▲ $503.702M ▲ $484.572M ▲
Q4-2025 $5.103M ▼ $769.867M ▲ $309.575M ▲ $460.292M ▲
Q3-2025 $8.305M ▲ $707.24M ▲ $250.259M ▲ $456.981M ▲
Q2-2025 $7.526M $689.697M $246.325M $443.372M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q2-2026 $22.598M ▼ $39.541M ▲ $-21.268M ▲ $-22.36M ▼ $-4.087M ▼ $28.743M ▲
Q1-2026 $29.175M ▲ $31.49M ▲ $-164.545M ▼ $142.454M ▲ $9.399M ▲ $17.946M ▼
Q4-2025 $16.327M ▲ $30.844M ▲ $-55.13M ▼ $21.084M ▲ $-3.202M ▼ $19.756M ▲
Q3-2025 $15.021M ▼ $21.036M ▼ $-26.493M ▼ $6.236M ▲ $779K ▲ $12.314M ▼
Q2-2025 $24.118M $41.63M $-10.525M $-32.466M $-1.361M $30.993M

Revenue by Products

Product Q3-2025Q4-2025Q1-2026Q2-2026
Agricultural
Agricultural
 $0 ▲$0 ▲$20.00M ▲$10.00M ▼
Bulk products
Bulk products
 $20.00M ▲$0 ▼$20.00M ▲$20.00M ▲
Food
Food
 $0 ▲$0 ▲$30.00M ▲$20.00M ▼
Nutrition
Nutrition
 $0 ▲$0 ▲$40.00M ▲$30.00M ▼
Other
Other
 $0 ▲$0 ▲$0 ▲$0 ▲
Pharmaceutical
Pharmaceutical
 $0 ▲$0 ▲$10.00M ▲$10.00M ▲

Five-Year Company Overview

Income Statement

Income Statement Hawkins shows a steady pattern of growth and improving profitability over the past several years. Sales have risen at a healthy pace, and profit margins have gradually widened, suggesting good pricing discipline and operating efficiency. Earnings per share have climbed meaningfully, although the most recent year hints at profit growth beginning to level off a bit despite higher revenue, which may reflect rising costs, mix shifts, or competitive pressure. Overall, the income statement points to a mature operator that has managed growth and profitability well, with some early signs that the “easy” margin gains may be behind it.

Balance Sheet

Balance Sheet The balance sheet looks generally solid and better than it did a few years ago. Total assets and shareholders’ equity have grown steadily, which indicates the business has been reinvesting and building its capital base. Debt has increased but remains moderate relative to the size of the company, and not out of line with its growth strategy. Cash on hand is quite lean, so the company likely relies on ongoing cash generation and credit lines rather than large cash buffers. In broad terms, Hawkins appears financially stable, with a sensible use of leverage and a stronger equity position over time.

Cash Flow

Cash Flow Hawkins consistently generates positive cash from its operations, which is a key strength. Operating cash flow has improved meaningfully over the five-year period, though it can move around from year to year, reflecting working capital swings in a chemical distribution business. Capital spending is regular but not excessive, aimed at supporting growth and infrastructure rather than large, one-off bets. Free cash flow has remained positive and has trended higher, giving the company flexibility to fund acquisitions, pay down debt, or return capital without stretching its finances. The main risk is that relatively low cash balances make continued strong cash generation important.

Competitive Edge

Competitive Edge Hawkins holds a strong, service-led position in several niche chemical markets rather than competing purely on commodity pricing. Its local service model, technical know-how, and long-standing customer relationships in water treatment, health and nutrition, and industrial chemicals create switching costs and loyalty that are hard for generic distributors to match. A wide geographic footprint and owned logistics network add a cost and reliability advantage. At the same time, its moat relies more on execution, relationships, and scale than on unique patents, so it must continually maintain service quality and cost discipline to defend its position against regional players and larger global chemical companies.

Innovation and R&D

Innovation and R&D Innovation at Hawkins is focused on applied chemistry, custom formulations, and process know-how rather than headline-grabbing R&D labs. The company invests in specialized blending, high-purity ingredients, and tailored water treatment programs, supported by chemists and technical experts working directly with customers. It is also using acquisitions to expand into higher-margin specialty areas and broaden its capabilities. Efforts to digitize operations, improve manufacturing efficiency, and deepen its health and nutrition offering are all aimed at nudging the business mix toward more specialized, stickier revenue. The main uncertainty is that much of this innovation is incremental and execution-driven, so its impact depends heavily on consistent management follow-through.

Summary

Overall, Hawkins looks like a steadily growing, well-run specialty chemical company with a service-heavy model and a durable niche. The financials show rising sales, improving margins, stronger equity, and reliable free cash flow, offset by modest but manageable growth in debt and low cash reserves. Competitively, its strengths lie in local presence, technical support, and diversified end markets rather than in proprietary technology. Future value creation will likely hinge on continued expansion in water treatment, a shift toward higher-margin specialty products, and disciplined integration of acquisitions. While it operates in a cyclical, regulated, and sometimes cost-pressured industry, Hawkins’ track record suggests resilience and a clear strategic direction, with the usual caveat that ongoing execution remains critical.

NEWS

October 29, 2025 · 4:10 PM UTC

Hawkins, Inc. Reports Second Quarter Fiscal 2026 Results

Read more

October 29, 2025 · 4:05 PM UTC

Hawkins, Inc. Declares Quarterly Cash Dividend of $0.19 Per Share

Read more

October 15, 2025 · 8:30 AM UTC

HAWKINS, INC. TO RELEASE SECOND QUARTER FISCAL 2026 FINANCIAL RESULTS ON OCTOBER 29, 2025

Read more

September 23, 2025 · 9:00 AM UTC

Marriott International and Hawkins Way Capital Announce Five Signed Agreements to Launch Series by Marriott™ in the United States

Read more

September 17, 2025 · 4:05 PM UTC

Hawkins, Inc. Recognized as One of America's Greatest Companies 2025 by Newsweek

Read more